Artelo Biosciences, Inc. (ARTL)

NASDAQ: ARTL · Real-Time Price · USD

0.8600

-0.0150 (-1.71%)

At close: Apr 1, 2025, 4:00 PM

0.9257

+0.0657 (7.64%)

After-hours: Apr 1, 2025, 4:02 PM EDT

Artelo Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	2020 - 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Aug '21 Aug 31, 2021	2020 - 2016
Selling, General & Admin	4.12	4.23	5.96	6.29	4.6	Upgrade
Research & Development	5.99	5.7	4.32	5.83	2.84	Upgrade
Operating Expenses	10.11	9.93	10.29	12.13	7.44	Upgrade
Operating Income	-10.11	-9.93	-10.29	-12.13	-7.44	Upgrade
Interest Expense	-	-	-0.01	-	-	Upgrade
Interest & Investment Income	-	-	0	0	0	Upgrade
EBT Excluding Unusual Items	-10.11	-9.93	-10.29	-12.12	-7.44	Upgrade
Gain (Loss) on Sale of Investments	0.28	0.64	0.21	0.02	0	Upgrade
Pretax Income	-9.83	-9.29	-10.08	-12.11	-7.44	Upgrade
Net Income	-9.83	-9.29	-10.08	-12.11	-7.44	Upgrade
Net Income to Common	-9.83	-9.29	-10.08	-12.11	-7.44	Upgrade
Shares Outstanding (Basic)	3	3	3	2	1	Upgrade
Shares Outstanding (Diluted)	3	3	3	2	1	Upgrade
Shares Change (YoY)	8.88%	4.48%	27.04%	79.12%	403.69%	Upgrade
EPS (Basic)	-3.05	-3.14	-3.56	-5.43	-5.97	Upgrade
EPS (Diluted)	-3.05	-3.14	-3.56	-5.43	-5.97	Upgrade
Free Cash Flow	-8.35	-8.21	-8.01	-8	-6.14	Upgrade
Free Cash Flow Per Share	-2.59	-2.77	-2.83	-3.59	-4.93	Upgrade
EBITDA	-	-	-	-	-7.44	Upgrade
D&A For EBITDA	-	-	-	-	0	Upgrade
EBIT	-10.11	-9.93	-10.29	-12.13	-7.44	Upgrade

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q